tiprankstipranks
Advertisement
Advertisement

GH Research Sets June 25, 2026 AGM and Tables Board, Auditor Votes

Story Highlights
  • GH Research scheduled its 2026 AGM for June 25 in Dublin with materials posted online.
  • Shareholders will vote on re-electing the full board and ratifying PwC Ireland as auditor.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
GH Research Sets June 25, 2026 AGM and Tables Board, Auditor Votes

Claim 55% Off TipRanks

GH Research ( (GHRS) ) has issued an announcement.

GH Research has called its 2026 annual general meeting for June 25, 2026, in Dublin, inviting shareholders of record as of May 1, 2026 to attend, vote and review the company’s 2025 Irish statutory financial statements. The company has circulated proxy materials and governance information online, reflecting its ongoing compliance with Irish corporate requirements and U.S. reporting standards.

At the AGM, all four current non-executive directors, including co-founder and chairman Florian Schönharting, will retire and stand for re-election, and shareholders will be asked to ratify PricewaterhouseCoopers Ireland as auditor for the 2026 financial year. While there is no “say on pay” vote under Irish law for this foreign private issuer, the board is unanimously recommending support for all resolutions, underlining a focus on continuity of governance and audit oversight for investors.

The most recent analyst rating on (GHRS) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on GH Research stock, see the GHRS Stock Forecast page.

Spark’s Take on GHRS Stock

According to Spark, TipRanks’ AI Analyst, GHRS is a Neutral.

The score is held back primarily by weak financial performance (no revenue, widening losses, and ongoing cash burn), partly offset by a strong, low-leverage balance sheet. Technicals are supportive with clear upward trend and positive momentum, while valuation remains a drag due to negative earnings and no dividend.

To see Spark’s full report on GHRS stock, click here.

More about GH Research

GH Research plc is an Ireland-based foreign private issuer listed on Nasdaq, operating in the biopharmaceutical sector with a focus on research and development activities. The company is governed by a fully non-executive board and follows Irish corporate law and U.S. securities regulations, reporting through Irish statutory financial statements and an annual Form 20-F filed with the U.S. SEC.

Average Trading Volume: 218,174

Technical Sentiment Signal: Buy

Current Market Cap: $1.48B

Learn more about GHRS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1